Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renaissance IPO ETF (NY: IPO )

45.37 +0.02 (+0.05%)
Official Closing Price Updated: 8:00 PM EDT, Oct 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Renaissance IPO ETF

< Previous 1 2 3 4 5 Next >
Rivian's Production Forecast Hits Bump, Supply Shortage Sends Shares Tumbling
Rivian's shares plunge 9% as the company slashes its annual production forecast due to a worsening supply shortage, now projecting 47,000 to 49,000 vehicles. 
Via Benzinga
What's Going On With XPeng Shares Today?
XPeng shares are rising following a stimulus announcement from China's Central Bank and the company's entry into the Qatari market. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Alaska Air Boosts Q3 Earnings Forecast Amid Solid Summer Travel Surge
Alaska Air Group has made a bold move, significantly raising its adjusted earnings per share forecast for the third quarter, now projecting a range of $2.15 to $2.25—well above the analyst consensus... 
Via Benzinga
BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race
BioAge Labs a biotech company focused on therapies for metabolic diseases, has filed for a $100 million IPO. Founded in 2015, the company plans to list on Nasdaq under the symbol BIOA. Their lead drug,... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
What's Going On With Nu Holdings Stock Today?
Nu added 5.2 million customers in the second quarter, reaching a total of 104.5 million customers globally by June 30, 2024, marking a 25% increase YoY. 
Via Benzinga
3 Interesting IPOs Worth Checking Out In 2024
Two promising tech stocks and a foreign EV scooter stock. 
Via Talk Markets
IPO Activity Slow To Recover
While Reddit's debut places some attention on new companies, overall IPO activity remains muted. 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
These Three September Listings Could Revive The IPO Market
Instacart, Arm, and Klaviyo are set to go public through IPOs in September. 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
Supreme Court Allows Merchants To Challenge Debit-Card Swipe Fees Beyond Six-Year Statute
The US Supreme Court ruled merchants can challenge debit-card swipe fees outside the 6-year statute, boosting their power against federal agencies. 
Via Benzinga
ETF Traps: 3 Funds That Promise Much But Deliver Little
These underperforming ETFs seemingly offer great promise, but their results have fallen far short of investor expectations so far. 
Via InvestorPlace
Topics ETFs
This Fintech Was Just Valued at $65 Billion. Could It Become 1 of 2024's Largest IPOs?
As market conditions improve, more companies are exploring going public. Here's one fintech investors should keep on their radar. 
Via The Motley Fool
Private Equity Bounces Back: EQT Raises $24B For Deals, Signals Listings Revival
EQT sees revival in M&A as firms float their best-performing companies to fund private equity deals. 
Via Benzinga
IPO Revival In 2024: Plaid, Chime, And Kim Kardashian's Skims Among Potential Market Movers
Market for IPOs expected to rebound in 2024 after inflation & interest rate rise hit new listings in 2022-23. 2023 saw 50% decrease in IPOs globally. 
Via Benzinga
Topics Economy Initial Public Offering
Exposures Interest Rates Securities Market
An Equities Innovation Update
Two innovative ETFs that fall well below the S&P 500 on a cumulative basis since inception. 
Via Talk Markets
KKR-Backed BrightSpring Health Services Sets Sail For IPO, Aiming To Curtail Debt
KKR & Co Inc (NYSE: KKR) backed BrightSpring Health Services, Inc. filed for an initial public offering ( 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
Fractyl Health, developing procedural and gene therapies for type 2 diabetes and obesity, filed an S-1 filing with the SEC on Thursday to raise up to $100 million in an initial public offering. 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
FAANG+ Leaving Newcomers In The Dust
Both the NYSE FAANG+ Index and Renaissance IPO ETF have put in place fresh 52-week highs in the past couple of days, however, zooming out, those fresh highs are on different planets. 
Via Talk Markets
Topics ETFs Initial Public Offering
Exposures Securities Market
Reddit Is Exploring a 2024 IPO. Could This Be Good News for Investment Banks?
IPO markets were virtually closed for much of the last year. Could falling interest rates help reverse the trend? 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF
There have not been many successful IPOs in 2023, so finding stock picks from the Renaissance IPO ETF won’t be easy. 
Via InvestorPlace
Topics ETFs Initial Public Offering
Exposures Securities Market
European Private Equity CVC Capital Partners Defies Market Pessimism, Weighs Amsterdam IPO Next Week
CVC Capital Partners, one of Europe's leading private equity groups with €161 billion under management, is set to make an audacious move by announcing its intention to go public in Amsterdam. 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Instacart and Arm's Stock Decline Sparks Concerns Over Tech Sector IPOs
Investors in recently listed tech companies Arm Holdings Plc (NASDAQ:  
Via Benzinga
Arm Debut Gathers Retail Investors' Love: ETFs In Focus
The successful market debut of ARM could pave its entry into a handful of ETFs due to the inclusion rules. 
Via Talk Markets
Topics ETFs
Instacart Targets Less Than $10B Valuation In Upcoming IPO, Significantly Lower Than Previous Funding Round
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Radiopharmaceuticals Startup RayzeBio Seeks Public Debut After Raising $400M From Investors
RayzeBio Inc, a San Diego company focused on radiopharmaceutical therapies for cancer, filed on Thursday to raise up to $1 
Via Benzinga
Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation
Waystar Inc, a provider of financial management software for hospitals and medical practices, is reportedly making strides toward an initial public offering (IPO) that could value the company up to $8... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
ETFs To Play The IPO Market Recovery
With stocks surging to new highs and inflation starting to ease, investors are warming up to IPOs again. 
Via Talk Markets
Second Time Charm: Sagimet Biosciences Seeks Public Debut With $75M IPO
On Friday, Sagimet Biosciences, a clinical-stage biopharmaceutical company, filed with the SEC to raise up to $75 million in an initial public off 
Via Benzinga
IPOs Quietly Lead This Market: 3 Top-Ranked Stocks To Consider
The Renaissance IPO ETF has considerably outperformed the broad market year-to-date. While some investors may choose to invest directly into the IPO ETF, parsing the components is a useful way to find... 
Via Talk Markets
Investment Banking Recovery? Here's What One Company Says.
Investment-bank deals are way down. Here's why and what investment bankers are looking for next. 
Via The Motley Fool
Flex's Nextracker Raises Over $638M Via Upsized IPO; To Begin Trading Today
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.